Stock AUROPHARMA AUROBINDO PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Delayed NSE India S.E.
Other stock markets
 05:19:02 2024-04-19 am EDT 		5-day change 1st Jan Change
1,089 INR -2.26% Intraday chart for Aurobindo Pharma +0.07% +0.48%
Apr. 07 Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President ­ R&D (Specialty Drug Delivery) CI
Apr. 02 Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India MT

Evolution of the average Target Price on Aurobindo Pharma

Price target over the last 5 years

History of analyst recommendation changes

0a686c1d60013d3d32a8c89f181bb1.3QiNHfVmIAt04K6SvtBT-UeoQHY0ylXrh0ElU1jRs2c.k3DObLIwclFE2enH85xjoTDMcxxxjg-stHNiCTXpyQKTMMxyowsTQzLNlg~f95651fb6840678fe87df6058024cebb

Analyst Recommendations on Aurobindo Pharma

Indian shares set to open lower as Powell keeps rate hike option open RE
Indian shares set to open flat amid risk aversion in global equities RE
INDIA STOCKS-Indian shares may open higher as US inflation data eases rate hike fears RE
Aurobindo Pharma Limited Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017; Provide Tax Rate Guidance for the Fiscal Year 2018 and 2019 CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
1,114 INR
Average target price
1,183 INR
Spread / Average Target
+6.14%
High Price Target
1,424 INR
Spread / Highest target
+27.77%
Low Price Target
940 INR
Spread / Lowest Target
-15.66%

Consensus detail

Consensus revision (last 18 months)

Ratings for Aurobindo Pharma

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AUROPHARMA Stock
  4. Consensus Aurobindo Pharma